The Icahn School of Medicine at Mount Sinai has received a $4 million, five-year P30 grant from NIH and the National Institute of Arthritis and Musculoskeletal and Skin Diseases to establish a Skin Biology and Diseases Resource-based Center.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
